Hepatocellular carcinoma: Global epidemiology

Digestive and Liver Disease

Volumn 33, Issue 2, 2001, Pages 115-117

  Tabor, E ^a  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B ANTIBODY; HEPATITIS B VACCINE;

ACUTE HEPATITIS; ARTICLE; CANCER INCIDENCE; CHRONIC HEPATITIS; CODON; DISEASE ASSOCIATION; FEMALE; GEOGRAPHIC DISTRIBUTION; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MALE; PREVALENCE; SEROCONVERSION; VIRUS CARRIER; VIRUS MUTATION; VIRUS REPLICATION;

EID: 0035074088     PISSN: 11258055     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1590-8658(01)80062-1     Document Type: Article

References (41)

1. Hepatocellular carcinoma in the world: Epidemiologic questions
2. A high prevalence of antibody to the hepatitis C virus in patients with hepatocellular carcinoma in Japan
3. Clinical aspects and epidemiology of hepatitis B and C viruses in hepatocellular carcinoma in Japan
4. Hepatitis C virus and hepatocellular carcinoma
5. Changes in the prevalence of hepatitis B and C infection in patients with hepatocellular carcinoma in the Nagasaki Prefecture, Japan
6. Rising incidence of hepatocellular carcinoma in the United States
7. Are increasing 5-year survival rates evidence of success against cancer?
8. Increased incidence of HCV-related hepatocellular [carcinoma] (HCC) from 1988 to 1997 in the State of Colorado: Implications for liver transplantation (LTx)
9. Increasing incidence of primary liver cancer. A matter of aging?
10. Trends in primary liver cancer
11. A clinicopathological study of hepatocellular carcinoma in Nagasaki, South-Western Japan: The association of hepatitis B and C viruses
12. Prevalence of HBV and HCV infection in Japanese patients with hepatocellular carcinoma
13. Hepatocellular carcinoma in Japan and its linkage to infection with hepatitis C virus
14. A low prevalence of anti-hepatitis C virus antibody in patients with hepatocellular carcinoma in Guangxi Province, Southern China
15. Development of hepatocellular carcinoma among patients with chronic liver disease due to hepatitis C viral infection
16. An analysis of 412 cases of hepatocellular carcinoma at a Western center
17. Hepatocellular carcinoma and hepatitis B virus: A prospective study of 22,707 men in Taiwan
18. Prospective study of hepatitis B and C viral infections, cigarette smoking, alcohol consumption, and other factors associated with hepatocellular carcinoma risk in Japan
19. Screening for hepatocellular carcinoma in chronic carriers of hepatitis B virus: Incidence and prevalence of hepatocellular carcinoma in a North American urban population
20. Viral pathogenesis of hepatocellular carcinoma in the United States
21. Silent hepatitis B virus in HBsAg-seronegative hepatocellular carcinoma patients
22. Silent hepatitis B virus infection in hepatitis C virus-associated hepatocellular carcinoma in Japan
23. Persistence of hepatitis B and hepatitis C viral genomes in primary liver cancers from HBsAg-negative patients: A study of a low-endemic area
24. Presence of hepatitis B and C viral genomes in US blood donors as detected by polymerase chain reaction amplification
25. Hot spot mutations in the hepatitis B virus X gene in hepatocellular carcinomas in Japan
26. A mutations in the basic core promoter of hepatitis B virus isolated from black Africans with hepatocellular carcinoma compared with asymptomatic carriers
27. Hot-spot mutations in hepatitis B virus X gene in hepatocellular carcinoma
28. Deletion mutants of the hepatitis B virus X gene in human hepatocellular carcinoma
29. HBV core promoter mutations prevail in patients with hepatocellular carcinoma from Guangxi, China
30. Analysis of the precore and core promoter DNA sequence in liver tissues from patients with hepatocellular carcinoma
31. Hepatitis B envelope protein mutants in human hepatocellular carcinoma tissues
32. Frequent integration of precore/core mutants of hepatitis B virus in human hepatocellular carcinoma tissues
33. Anti-hepatitis C virus sero-conversion in blood donors in Japan
34. Very low incidence rates of community-acquired hepatitis C virus infection in company employees, long-term inpatients, and blood donors in Japan
35. HCV infection and liver cancer mortality in a Japanese population with HTLV-I
36. Hepatitis C virus seroconversion rate in a hyperendemic area of HCV in Japan: A prospective study
37. Evolution of hepatitis C virus markers following seroconversion in a community-based population in Japan
38. A relationship between the evolution of hepatitis C virus variants, liver damage, and hepatocellular carcinoma in patients with hepatitis C viremia
39. A multivariate analysis of risk factors for hepatocellular carcinogenesis: A prospective observation of 795 patients with viral and alcoholic cirrhosis
40. Most of the patients with cirrhosis in Japan die from hepatocellular carcinoma
41. Prevalence of hepatocellular carcinoma in patients with alcoholic cirrhosis and prior exposure to hepatitis C